oncology News

“Evening of Good Taste” will benefit the ongoing expansion of the Gertrude & Louis Feil Cancer Center. The center is the only one on Long Island that is equipped with the Varian Novalis Tx™, da Vinci® Surgical System and Gamma Knife®.

Dr. Rajiv Datta, chair of the dept. of surgery and medical director of the Gertrude & Louis Feil Cancer Center at South Nassau Communities Hospital, was cited by the AAPIQLI for his leadership, accomplishments and excellence as a cancer surgeon.

Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

Claude Gimmi at Boehringer to present at Oncology Partnering Conference – Feb 27-28, 2012, Las Vegas

Anne Altmeyer, Executive Director, Business Development & Licensing, Oncology, at Novartis as a Panelist at the Oncology Partnering and Deal-making Conference (February 27-28, 2012 in Las Vegas, NV)

Springer Healthcare, has signed an extensive three-year reprints and sales agreement with the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer.

Head of Methodological Biostatistics, Lisa Comarella, is attending the annual Breast Cancer event in San Antonio, Texas.

CHI’s Oncology Clinical Trials conference will highlight two case studies by Seattle Genetics’ Eric Sievers, M.D., Vice President, Clinical Affairs, and Elaine S. Waller, Pharm.D., M.B.A., Senior Vice President, Regulatory Affairs.

CHI’s Oncology Clinical Trials: Bringing Targeted & Tailored Cancer Therapy will take place on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2012.

There are about 2.5 million breast cancer survivors in the U.S., including women still being treated. Underserved and minority women have the highest mortality, lowest survival, and fastest-rising incidence rates for breast cancer in the U.S.

Did you know cancer is the number one cause of death in dogs over 2? Over 266 handlers and 383 dogs competed in the Texas Agility Shoot-Out to raise over $42,000 for Canine Cancer Research. Together, We are the Cure!

Program greatly extends access to Fertility Preservation services

The prestigious ACR-ASTRO accreditation is awarded only to facilities meeting specific Practice Guidelines and Technical Standards developed by ACR and ASTRO.

The afternoon of golf was followed by an evening of fine dining, camaraderie and fun, including a lavish buffet and raffle prizes ranging from tickets to professional sporting events to foursomes at the area’s most prestigious courses.

The surgery was performed on a 63-year-old female patient who was an active smoker with a history of coughing up traces of blood, a common symptom of lung cancer.

Oncology Systems Limited (OSL) has signed a direct agreement with US company, Math Resolutions, to distribute its Dosimetry Check Software throughout the UK and Ireland.

Cancer Talk LiveSM is designed specifically for oncology specialists who are actively involved in oncology disease management. Improving Outcomes in Breast Cancer is an update from the San Antonio Breast Cancer Symposium 2010.

OncoBeat Chicago 2011: Reporting the News...Beating Cancer is a series of 9 interviews based on key highlights and data from the American Society of Clinical Oncologists (ASCO) conference held in Chicago, June 3 - 7, 2011.

Charlotte, NC based Novarus Mobile Technologies, LLC launches their latest iPhone application – Breast Cancer Connect.

A new global market report from the market research firm Industry Experts reveals that the market for Tissue Engineering is projected to touch US$27 billion by 2018 from an estimated US$6.6 billion in 2008, witnessing an healthy CAGR of 15%.

After a national search and approval by the LSU Board of Supervisors, Dr. Glenn Mills has been named Director of the Feist-Weiller Cancer Center at LSU Health Shreveport.

Kalos Therapeutics, Inc. Co Founder George Colberg to Present at BIOCOM's Global Life Science Partnering Conference 2012, La Jolla, CA, USA,Thursday February 2nd, 2012 Being held at the Lodge at Torrey Pines in La Jolla CA

“Evening of Good Taste” will benefit the ongoing expansion of the Gertrude & Louis Feil Cancer Center. The center is the only one on Long Island that is equipped with the Varian Novalis Tx™, da Vinci® Surgical System and Gamma Knife®.

Join us on the 14th and 15th March 2012 at the Copthorne Tara Hotel to gain top tips from experienced industry figures discussing ways in which to develop drugs in a clever way with reduced production time

Specialists in Urology (SIU) and Premiere Oncology will host a free cancer symposium discussing “The Real Scoop on PSA Screening - Waste of Time or Life Saving Test?” on Saturday, February 4, from 9 a.m.-noon at the Coconut Point Hyatt.

EventPilot brings mobile technology and convenience to thousands of oncology specialists and medical professionals participating in the 2012 Genitourinary (GU) Cancers Symposium in San Francisco

Dr. Rajiv Datta, chair of the dept. of surgery and medical director of the Gertrude & Louis Feil Cancer Center at South Nassau Communities Hospital, was cited by the AAPIQLI for his leadership, accomplishments and excellence as a cancer surgeon.

Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

Professional oncologists attending the 2012 Gastrointestinal Cancers Symposium can use the sophisticated medical event app EventPilot to conveniently access updated event information and research abstracts on their smartphone

Claude Gimmi at Boehringer to present at Oncology Partnering Conference – Feb 27-28, 2012, Las Vegas

Anne Altmeyer, Executive Director, Business Development & Licensing, Oncology, at Novartis as a Panelist at the Oncology Partnering and Deal-making Conference (February 27-28, 2012 in Las Vegas, NV)

C. Glenn Begley, Vice President and Global Head of Hematology and Oncology Research at Amgen, is giving a Featured presentation at the 3rd Cancer Targets and Therapeutics Conference (Feb 27-28, 2012 in Las Vegas, NV)

Pharmaceutical industry decision-makers, scientists, researchers, technology developers and investors will gather in one location at GTC’s Biomarker Summit 2012, March 15-16 in San Diego, CA.

Springer Healthcare, has signed an extensive three-year reprints and sales agreement with the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer.

Treating breast cancer with radiation at the time of surgery helps patients who meet specific criteria avoid follow-up radiation and resume normal activities

Head of Methodological Biostatistics, Lisa Comarella, is attending the annual Breast Cancer event in San Antonio, Texas.

Kalos Therapeutics, Inc. to Present at Life Sciences Summit 2011 Life Sciences Summit 2011 to be held November 16-17 in New York, New York

CHI’s Oncology Clinical Trials conference will highlight two case studies by Seattle Genetics’ Eric Sievers, M.D., Vice President, Clinical Affairs, and Elaine S. Waller, Pharm.D., M.B.A., Senior Vice President, Regulatory Affairs.

Epizyme & Eisai to give a Featured Joint Presentation at the Oncology Partnering and Deal-making Conference (Las Vegas, NV on February 27-28, 2012)

CHI’s Oncology Clinical Trials: Bringing Targeted & Tailored Cancer Therapy will take place on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2012.

Advanced Cancer Therapeutics CEO to Present Preclinical Data on Cancer Metabolism Drug at MidAmerica Healthcare Venture Forum

Long Beach, CA 10/14/2011 – Dr. Rehana Baqai, along with the gifted staff at The Oncology Institute of Hope and Innovation achieve great level of success in their Long Beach Division.

Glendale, CA 9/30/2011 – The Oncology Institute of Hope and Innovation continues to lead on the foundation of it’s mission statement in serving the community of Glendale, California.

There are about 2.5 million breast cancer survivors in the U.S., including women still being treated. Underserved and minority women have the highest mortality, lowest survival, and fastest-rising incidence rates for breast cancer in the U.S.

Jeffrey S. Weber, MD, PhD, of the H. Lee Moffitt Cancer Center leads a 1-day conference to provide clinicians with an update on the science of melanoma, pertinent clinical trial information, investigational agents, and their unusual adverse effects.

Dr. Daniel Jae Kim, along with the outstanding oncologists and hematologists from The Oncology Institute of Hope and Innovation, are celebrating 14 months of success at their Anaheim center.

Did you know cancer is the number one cause of death in dogs over 2? Over 266 handlers and 383 dogs competed in the Texas Agility Shoot-Out to raise over $42,000 for Canine Cancer Research. Together, We are the Cure!

Program greatly extends access to Fertility Preservation services

The prestigious ACR-ASTRO accreditation is awarded only to facilities meeting specific Practice Guidelines and Technical Standards developed by ACR and ASTRO.

Cancer Fundraiser set for September 17 at Acuna Park.

Data Capture Expanded to Directly Connect Biomarker Testing to Cancer Treatment

The afternoon of golf was followed by an evening of fine dining, camaraderie and fun, including a lavish buffet and raffle prizes ranging from tickets to professional sporting events to foursomes at the area’s most prestigious courses.

The producers of "Inside Business Report" are pleased to announce that US Oncology Research will be featured in an upcoming segment related to "Advancements in Cancer Treatment and Care" as part of the show's Medical Minutes series.

Netscribes (India) Pvt. Ltd., launches a report on the Oncology Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series.

Drs. Roy and Andrew Ashikari, Pond Kelemen bring world-renowned talents to HVHC’s new Cancer Center

Reportstack.com has announced the addition of Insight Pharma's 'Commercializing Biomarkers in Therapeutic and Diagnostic Applications' to their offering

Sigma® Life Science Launches Genetically Modified Human Cell Lines for Breast Cancer Research CompoZr® ZFN-modified breast cancer cell lines will accelerate drug discovery and enhance basic research

The surgery was performed on a 63-year-old female patient who was an active smoker with a history of coughing up traces of blood, a common symptom of lung cancer.

In this ASCO-related newsletter, healthcare professionals may receive the equivalent of 1.0 CME credit for Advances in the Management of Non-Small Cell Lung Cancer. Featured contents include treatment of early stage NSCLC and advanced stage NSCLC.

Doctors.net.uk, the largest and most active professional network of doctors in the UK, has launched a unique resource for oncologists, haematologists, GPs and other medical professionals involved in cancer care.

Announcing the release of an interactive newsletter, featuring the latest innovations and technologies in hematological malignancies presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.

Oncology, Metabolic Disorders and CNS Command Robust Late Stage Pipeline

Oncology Systems Limited (OSL) has signed a direct agreement with US company, Math Resolutions, to distribute its Dosimetry Check Software throughout the UK and Ireland.

Cancer Talk LiveSM is designed specifically for oncology specialists who are actively involved in oncology disease management. Improving Outcomes in Breast Cancer is an update from the San Antonio Breast Cancer Symposium 2010.

OncoBeat Chicago 2011: Reporting the News...Beating Cancer is a series of 9 interviews based on key highlights and data from the American Society of Clinical Oncologists (ASCO) conference held in Chicago, June 3 - 7, 2011.

New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

In 2009, the Center treated a total of 1,326 patients, including 1,047 new cases and 279 cases with recurrent cancer or cancer in progression. South Nassau is a recipient of the prestigious ACoS Commission on Cancer Outstanding Achievement Award.